GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanco Animal Health Inc (STU:5EA) » Definitions » Net Interest Income (for Banks)

Elanco Animal Health (STU:5EA) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is Elanco Animal Health Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Elanco Animal Health Business Description

Traded in Other Exchanges
Address
2500 Innovation Way, Greenfield, IN, USA, 46140
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.